Intra-Cellular Therapies Inc (ITCI) - Financial and Strategic SWOT Analysis Review



Intra-Cellular Therapies Inc (ICTI) is a biopharmaceutical company that develops drugs for the treatment of neuropsychiatric and neurodegenerative diseases. The company is investigating its lead pipeline candidate, lumateperone (ITI-007), for the treatment of schizophrenia; bipolar disorder; behavioral disturbances associated with dementia and Alzheimers disease; sleep disturbances associated with neuro-psychiatric disorders; major depressive disorder and autism. It is evaluating phosphodiesterase inhibitor molecule, ITI-214, for the treatment of heart failure and Parkinsons disease. It is also advancing its pre-clinical candidates for substance use disorder, depression, and pain management. The company employs its phosphodiesterase platform and other proprietary chemistry platforms for advancing drugs for the treatment of central nervous system and other disorders. ICTI is headquartered in New York, the US.

Intra-Cellular Therapies Inc Key Recent Developments

May 07,2020: Intra-Cellular Therapies reports first quarter 2020 financial results and provides corporate update
Mar 02,2020: Intra-Cellular Therapies reports fourth quarter and full-year 2019 financial results and provides corporate update
Nov 05,2019: Intra-Cellular Therapies provides corporate update and reports third quarter 2019 financial results
Aug 07,2019: Intra-Cellular Therapies provides corporate update and reports second quarter 2019 financial results
Jul 08,2019: Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression

This comprehensive SWOT profile of Intra-Cellular Therapies Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intra-Cellular Therapies Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

Intra-Cellular Therapies Inc - Key Information
Intra-Cellular Therapies Inc - Overview
Intra-Cellular Therapies Inc - Key Employees
Intra-Cellular Therapies Inc - Key Employee Biographies
Intra-Cellular Therapies Inc - Key Operational Heads
Intra-Cellular Therapies Inc - Major Products and Services
Intra-Cellular Therapies Inc - History
Intra-Cellular Therapies Inc - Company Statement
Intra-Cellular Therapies Inc - Locations And Subsidiaries
Intra-Cellular Therapies Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Intra-Cellular Therapies Inc - Business Description
Intra-Cellular Therapies Inc - Corporate Strategy
Intra-Cellular Therapies Inc - SWOT Analysis
SWOT Analysis - Overview
Intra-Cellular Therapies Inc - Strengths
Intra-Cellular Therapies Inc - Weaknesses
Intra-Cellular Therapies Inc - Opportunities
Intra-Cellular Therapies Inc - Threats
Intra-Cellular Therapies Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Intra-Cellular Therapies Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



Intra-Cellular Therapies Inc, Key Information
Intra-Cellular Therapies Inc, Key Ratios
Intra-Cellular Therapies Inc, Share Data
Intra-Cellular Therapies Inc, Major Products and Services
Intra-Cellular Therapies Inc, History
Intra-Cellular Therapies Inc, Key Employees
Intra-Cellular Therapies Inc, Key Employee Biographies
Intra-Cellular Therapies Inc, Key Operational Heads
Intra-Cellular Therapies Inc, Other Locations
Intra-Cellular Therapies Inc, Subsidiaries
Intra-Cellular Therapies Inc, Key Competitors
Intra-Cellular Therapies Inc, SWOT Analysis
Intra-Cellular Therapies Inc, Ratios based on current share price
Intra-Cellular Therapies Inc, Annual Ratios
Intra-Cellular Therapies Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



Intra-Cellular Therapies Inc, Performance Chart
Intra-Cellular Therapies Inc, Ratio Charts
 


Vital Therapies Inc (VTL) - Medical Equipment - Deals and Alliances Profile.

Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver

USD 250 View Report

BioRestorative Therapies Inc (BRTX) - Financial and Strategic SWOT Analysis Review

BioRestorative Therapies Inc (BRTX) - Financial and Strategic SWOT Analysis Review

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available